Literature DB >> 19296086

Functional and perceived response to intra-articular hyaluronan injection in patients with knee osteoarthritis: persistence of treatment effects over 5 months.

Kristin Briem1, Michael J Axe, Lynn Snyder-Mackler.   

Abstract

Intra-articular injections of hyaluronic acid are currently indicated as a symptom-modifying treatment for knee osteoarthritis to palliate symptoms and improve function. A series of three to five weekly injections are typically delivered once per week and a period of at least 6 months must pass between consecutive injection series. Little is known about why some patients do not respond to this treatment or about its effects on outcome measures recorded during functional activities. In addition to investigating short-term self-report and measured functional changes, the purpose of this study was to evaluate the persistence of treatment effects over the typical time interval between consecutive treatment series. According to the a priori definition for response to treatment, over two-thirds of patients experienced improved knee function during the typical period between series of intra-articular injection of hyaluronic acid while a one-third did not demonstrate a change in self-report scores. Differences in response were similarly seen between groups in functional tests. Many had immediate benefits and although some did not retain their gains, others experienced a delayed response in the following months. Knee flexion range of motion was related to self-report and tested function, and improvements in range of motion were associated with concurrent improvements in other functional measures across the testing period. A short functional test and knee-specific questionnaire may provide an index that provides an indication as to whether or not a particular patient is likely to respond to hyaluronan injections. Such information may provide valuable input when decisions are made regarding which treatment option is recommended to individuals with knee osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19296086     DOI: 10.1007/s00167-009-0760-x

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  33 in total

1.  The role of knee alignment in disease progression and functional decline in knee osteoarthritis.

Authors:  L Sharma; J Song; D T Felson; S Cahue; E Shamiyeh; D D Dunlop
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

Review 2.  An update on the epidemiology of knee and hip osteoarthritis with a view to prevention.

Authors:  D T Felson; Y Zhang
Journal:  Arthritis Rheum       Date:  1998-08

3.  Collateral ligament laxity of the knee. Long-term comparison between plateau fractures and normal.

Authors:  T M Moore; M H Meyers; J P Harvey
Journal:  J Bone Joint Surg Am       Date:  1976-07       Impact factor: 5.284

4.  Development of a patient-reported measure of function of the knee.

Authors:  J J Irrgang; L Snyder-Mackler; R S Wainner; F H Fu; C D Harner
Journal:  J Bone Joint Surg Am       Date:  1998-08       Impact factor: 5.284

5.  Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project.

Authors:  Alan L Elliott; Virginia B Kraus; Gheorghe Luta; Thomas Stabler; Jordan B Renner; Janice Woodard; Anca D Dragomir; Charles G Helmick; Marc C Hochberg; Joanne M Jordan
Journal:  Arthritis Rheum       Date:  2005-01

6.  A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results.

Authors:  J-P Raynauld; G W Torrance; P A Band; C H Goldsmith; P Tugwell; V Walker; M Schultz; N Bellamy
Journal:  Osteoarthritis Cartilage       Date:  2002-07       Impact factor: 6.576

7.  Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis.

Authors:  Grace H Lo; Michael LaValley; Timothy McAlindon; David T Felson
Journal:  JAMA       Date:  2003-12-17       Impact factor: 56.272

8.  Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis.

Authors:  A C Jones; M Pattrick; S Doherty; M Doherty
Journal:  Osteoarthritis Cartilage       Date:  1995-12       Impact factor: 6.576

9.  The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone.

Authors:  M E Adams; M H Atkinson; A J Lussier; J I Schulz; K A Siminovitch; J P Wade; M Zummer
Journal:  Osteoarthritis Cartilage       Date:  1995-12       Impact factor: 6.576

Review 10.  Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment.

Authors:  Victor M Goldberg; Richard D Coutts
Journal:  Clin Orthop Relat Res       Date:  2004-02       Impact factor: 4.176

View more
  3 in total

1.  [Hyaluronate acid for treatment of chondromalacia patellae: a 52-week follow-up study].

Authors:  Shuai Zhang; Mengyan Jia; Yuqiang Luo; Xinguang Wang; Zhanjun Shi; Jun Xiao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-07-30

2.  The efficacy and safety of intra-articular injection of hyaluronic acid in the knee and physical therapy agents to treat Kashin-Beck disease: A prospective interventional study.

Authors:  Pinglin Yang; Xiong Guo; Xijing He; Quanjin Zang; Guoyu Wang; Peng Xu; Weizhuo Wang
Journal:  Exp Ther Med       Date:  2016-05-19       Impact factor: 2.447

Review 3.  Intraarticular Hyaluronic Acid Preparations for Knee Osteoarthritis: Are Some Better Than Others?

Authors:  David Webner; Yili Huang; Charles D Hummer
Journal:  Cartilage       Date:  2021-05-28       Impact factor: 4.634

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.